| Schwabe Pharma AG - Selomida Haut, Pulver zur Herstellung einer Lösung zum Einnehmen | | 65359 | | 01 | | Selomida Haut | | Pulver zur Herstellung einer Lösung zum Einnehmen | | D11AZ | | Sonstige Dermatologika, Homöopathika | | 09.08.2016 | | |
| | Composition | | No.1 calcium fluoratum (HAB) D12 1.25 g, No.4 kalium chloratum (HAB) D6 (HAB 6) 1.25 g, No.6 kalium sulfuricum (HAB) D6 (HAB 6) 1.25 g, No.8 natrium chloratum (HAB) D6 (HAB 6) 1.25 g, No.11 silicea (HAB) D12 1.25 g, No.21 zincum chloratum D12 (HAB 6) 1.25 g, lactosum monohydricum 7.5 g, ad pulverem pro charta 7.5 g. | | Packungsbestandteile | | | | | | | | Active Agent | Dose |
|---|
| | 1.25 g | | | 1.25 g | | | 1.25 g |
| | | | Inactive agents | Dose |
|---|
| Lactose Monohydrate | 7.5 g | | | 1.25 g | | | 1.25 g | | | 1.25 g |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 30 x 7.5 g | PR | PR | D | | No | | 002 | 7.5 g | PR | PR | D | | Yes |
|
|
